Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi–Goutières syndrome
Keyword(s):
Keyword(s):
2020 ◽
Vol 145
(2)
◽
pp. 489-490
◽
Keyword(s):
2020 ◽
Vol 6
(4)
◽
pp. 406-417